{
    "SPADE_N_00027": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_00027",
            "Peptide Name": "Lantibiotic epilancin 15X (Bacteriocin)",
            "Source": "Staphylococcus epidermidis 15X154 (Gram-positive bacteria)",
            "Family": "Belongs to the type A lantibiotic family (Class I bacteriocin)",
            "Gene": "Not found",
            "Sequence": "ASIVKTTIKASKKLCRGFTLTCGCHFTGKK",
            "Sequence Length": 30,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P86047"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+"
            ],
            "Target Organism": "Gram-positive bacteria:resistant bacterial strains Staphylococcus aureus (MRSA) and VRE.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "The molecule contains ten post-translationally modified amino acids, three lanthionine ring structures and a hydroxy-propionyl N-terminal moiety.",
            "Formula": "C142H243N41O38S3",
            "Mass": 3228.9,
            "PI": 10.07,
            "Net Charge": 8,
            "Hydrophobicity": 0.0,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Lanthionine-containing peptide antibiotic (lantibiotic) active on Gram-positive bacteria",
            "PTM": "There are one Lactic acid (S1), one 2,3-didehydroalanine (S3) and three 2,3-dehydrobutyrines (T7; T8; T28); also one Lanthionine (S12-C16) and two Beta-methyllanthionines (T20-C23; T22-C25).",
            "Literature": [
                {
                    "Title": "Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.",
                    "Pubmed ID": "15792796",
                    "Reference": "FEBS Lett. 2005 Mar 28;579(9)1917-1922.",
                    "Author": "Ekkelenkamp MB, Hanssen M, Danny Hsu ST, de Jong A, Milatovic D, Verhoef J, van Nuland NA.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15792796"
                }
            ],
            "Frequent Amino Acids": "KTC",
            "Absent Amino Acids": "DEMNOPQUWY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 21,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05587",
                    "Similarity": 1.0,
                    "Sequence": "SASIVKTTIKASKKLCRGFTLTCGCHFTGKK"
                },
                {
                    "SPADE_ID": "SPADE_N_05609",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "ASVVKTTIKASKKLCKGATLTCGCNITGKK"
                },
                {
                    "SPADE_ID": "SPADE_N_08117",
                    "Similarity": 0.7666666666666667,
                    "Sequence": "AAIVKAAIKAAKKLCRGFALACGCHFAGKK"
                }
            ]
        }
    }
}